Consistent with these findings, the authors found that HML-2 expression was located in the same tumor cells in GBM as those that expressed critical markers of tumor stem cell biology, such as OCT4, Nestin, and SOX-2 (6). This evidence concerns the gene CLEC10A and neoplasm.